HeartWare Limited Product Pipeline Analysis

SUMMARY

HeartWare Limited Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a HeartWare Limited's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
2.3 Financial Performance 8
2.4 Industry Outlook -- Cardiovascular Devices 8
3 Business Description 9
3.1 Business Overview 9
3.2 Major Products and Services 9
3.2.1 Overview 9
4 History 10
5 Competitors 11
6 Key Employees 12
7 Key Employee Biographies 13
8 Company Statement 15
9 Locations And Subsidiaries 18
9.1 Head Office 18
9.2 Other Locations & Subsidiaries 18
10 Recent Developments 19
10.1 Strategy And Business Planning 19
10.1.1 Apr 18, 2008: HeartWare Moves To New Manufacturing Facility In US 19
10.2 Financial Announcements 19
10.2.1 Apr 18, 2008: HeartWare Reports 2007 Results 19
10.2.2 Aug 31, 2007: HeartWare Reports H1 2007 Results 21
10.2.3 Feb 28, 2007: HeartWare Reports 2006 Results 22
10.3 Corporate Communications 24
10.3.1 Apr 30, 2008: HeartWare Appoints New Board Member 24
10.3.2 Apr 29, 2008: HeartWare Appoints CMO 24
10.3.3 Sep 04, 2006: HeartWare Appoints New CEO 25
10.4 Product News 25
10.4.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE 25
10.4.2 Jul 13, 2007: Heartware Announces Clinical Trial Update 26
10.4.3 Mar 09, 2007: Heartware Ltd To Launch HVAD Heart Device In Europe 26
10.4.4 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom 27
10.5 Product Approvals 27
10.5.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE 27
10.5.2 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom 28
10.6 Clinical Trials 28
10.6.1 Jul 13, 2007: Heartware Announces Clinical Trial Update 28
11 HeartWare Limited Pipeline Products 29
11.1 HeartWare Limited Product Pipeline Analysis 29
11.1.1 HeartWare Limited Pipeline Products By Equipment Type 29
11.1.2 HeartWare Limited Pipeline Products By Development Stage 30
11.1.3 HeartWare Limited Pipeline Products By Therapy Area 31
11.1.4 HeartWare Limited Pipeline Products By Clinical Trials 31
11.1.5 HeartWare Limited Pipeline Products By News Summary 32
11.2 HVAD System 32
11.2.1 Product Description 33
11.2.2 Product Status 33
11.2.3 Clinical Trials 33
11.2.4 Product Milestone 34
11.2.5 Product Patent Details 34
11.3 MVAD System 35
11.3.1 Product Description 35
11.3.2 Product Status 36
11.3.3 Product Patent Details 36
11.4 HeartWare IV-VAD 37
11.4.1 Product Description 37
11.4.2 Product Status 37
11.4.3 Product Patent Details 37
11.5 PedVAD 38
11.5.1 Product Description 38
11.5.2 Product Status 38
11.6 TETS Technology 39
11.6.1 Product Description 39
11.6.2 Product Status 39
12 Appendix 40
12.1 Methodology 40
12.1.1 Coverage 40
12.1.2 Secondary Research 41
12.1.3 Primary Research 41
12.1.4 Expert Panel Validation 42
12.2 Contact Us 42
12.3 About Global Markets Direct 42
12.4 Disclaimer 42

1.1 List of Tables
Table 1: HeartWare Limited,Key Facts 8
Table 2: HeartWare Limited, Key Employees, 12
Table 3: HeartWare Limited, Other Locations 18
Table 4: HeartWare Limited Pipeline Products by Equipment Type 29
Table 5: HeartWare Limited Pipeline Products By Development Stage 30
Table 6: HeartWare Limited Pipeline Products By Therapy Area 31
Table 7: HeartWare Limited Pipeline Products By Clinical Trials 31
Table 8: HeartWare Limited Pipeline Products By News Summaries 32

1.2 List of Figures
Figure 1: HeartWare Limited Pipeline Products By Development Stage 30
Figure 2: HeartWare Limited Pipeline Products By News Summary 32
Figure 3: Global Markets Direct Methodology 40